Monitor for future prospectus supplements or 8-K filings that may disclose actual offering terms, size, and use of proceeds. The current amendment is routine and does not trigger immediate trading implications.
Price Chart
Executive Summary
Allarity Therapeutics filed an amendment to its S-3 shelf registration to update the auditor consent, with no changes to the prospectus. The filing is administrative and does not disclose new offering terms, size, or pricing. This maintains the company's ability to issue securities on a delayed or continuous basis.
Key Facts
- Filing is an exhibits-only amendment to a previously filed S-3 shelf registration (File No. 333-293420).
- Purpose is to update the auditor consent (Exhibit 23.2) from Wolf & Company, P.C.
- No changes were made to the prospectus or offering details; no offering size, share count, or pricing disclosed.
- Original S-3 was filed on February 12, 2026, and allows for future issuance of unspecified amounts of securities.
Financial Impact
No immediate financial impact — no capital raised in this filing. Potential for future dilution if shares are issued under the shelf.
Risk Factors
- Future ATM or follow-on offerings could lead to significant dilution given the small market cap ($22M).
- Lack of disclosed offering terms increases uncertainty around timing and scale of potential capital raises.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-047385 |
| Document: ea028739601ex23-2.htm | 0001213900-26-047385 |
| Document: 0001213900-26-047385-index-headers.html | 0001213900-26-047385 |
| Document: 0001213900-26-047385-index.html | 0001213900-26-047385 |
| Document: 0001213900-26-047385.txt | 0001213900-26-047385 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $1.04 | awaiting T+20 | — | $0.9200 (−11.54%) |
Sep 29, 2026 28d ago | 8-K | $0.9651 | awaiting T+20 | — | $0.9200 (−4.67%) |
Sep 28, 2026 29d ago | Press Release | $0.9684 $0.9151 | ▼ −5.50% | ▼ −5.47% | $0.9200 (−5.00%) |
Sep 16, 2026 5w ago | 8-K | $1.16 $0.8699 | ▼ −24.68% | ▼ −27.86% | $0.9200 (−20.35%) |
Sep 14, 2026 6w ago | 8-K | $1.17 $0.8601 | ▼ −26.49% | ▼ −28.75% | $0.9200 (−21.37%) |
Sep 11, 2026 6w ago | Press Release | $1.22 $0.9900 | ▼ −18.85% | ▼ −20.72% | $0.9200 (−24.59%) |
Aug 14, 2026 10w ago | Press Release | $1.37 $1.17 | ▼ −14.60% | ▼ −12.61% | $0.9200 (−32.85%) |
Jul 1, 2026 16w ago | 8-K | $1.33 $1.16 | ▼ −12.78% | ▼ −10.60% | $0.9200 (−30.83%) |
Jun 22, 2026 18w ago | 8-K | $1.36 $1.19 | ▼ −12.50% | ▼ −12.35% | $0.9200 (−32.35%) |
Jun 18, 2026 18w ago | Press Release | $1.43 $1.17 | ▼ −18.18% | ▼ −18.71% | $0.9200 (−35.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers